Understanding the Market
GLOBAL CANCER THERAPEUTICS MARKET
Worldwide, in 2020, there were (excluding non-melanoma skin cancer) an estimated 18 million cases of cancer and 10 million cancer deaths (GLOBCAN 2020 International Agency for Research on Cancer)
It is estimated that the global cancer therapeutics market will reach around USD 278 billion by 2027, growing at a CAGR of 7.5% during the forecast period.
The size of the market for ONKONEK is likely to be substantial given its broad applicability to a wide range of solid tumours and its potential minimal normal tissue toxicity
BIG PHARMA DEALS IN 2020 WITH BIOTECHS LIKE SYNTHERIX
GSK/IDEAVA for IDE397 to start phase I studies
(Total value $3,030M Upfront payment $100M)
MERCK/ Taiho KRAS inhibitor
(Total value $2,550 Upfront payment $50M)
ROCHE/Blueprint RET inhibitor Pralsetinib to start phase I/II clinical study
(Total value $1,720M Upfront payment $675M)